SHENZHEN HEPALINK PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 9989 for the last quarter is 1.34 B HKD, and it's 15.25% lower compared to the previous quarter. The net income of Q3 24 is 126.69 M HKD.